| Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet T Barbui, G Barosi, G Birgegard, F Cervantes, G Finazzi, M Griesshammer, ... Journal of Clinical Oncology 29 (6), 761, 2011 | 830 | 2011 |
| Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012 | 811 | 2012 |
| Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and … RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ... Leukemia 24 (6), 1121-1127, 2010 | 734 | 2010 |
| Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 51 (6), 786-792, 2016 | 383 | 2016 |
| Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ... Leukemia 29 (10), 2062-2068, 2015 | 383 | 2015 |
| Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party … N Kröger, E Holler, G Kobbe, M Bornhäuser, R Schwerdtfeger, ... Blood, The Journal of the American Society of Hematology 114 (26), 5264-5270, 2009 | 380 | 2009 |
| Antilymphocyte globulin for prevention of chronic graft-versus-host disease N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ... New England Journal of Medicine 374 (1), 43-53, 2016 | 344 | 2016 |
| International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation M Cavo, SV Rajkumar, A Palumbo, P Moreau, R Orlowski, J Bladé, ... Blood 117 (23), 6063-6073, 2011 | 341 | 2011 |
| Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, ... Bone marrow transplantation 50 (8), 1037-1056, 2015 | 316 | 2015 |
| Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma N Kröger, R Schwerdtfeger, M Kiehl, HG Sayer, H Renges, T Zabelina, ... Blood, The Journal of the American Society of Hematology 100 (3), 755-760, 2002 | 301 | 2002 |
| Outcome of transplantation for myelofibrosis KK Ballen, S Shrestha, KA Sobocinski, MJ Zhang, A Bashey, BJ Bolwell, ... Biology of Blood and Marrow Transplantation 16 (3), 358-367, 2010 | 269 | 2010 |
| Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice T Ruutu, A Gratwohl, T De Witte, B Afanasyev, J Apperley, A Bacigalupo, ... Bone marrow transplantation 49 (2), 168-173, 2014 | 263 | 2014 |
| Revised response criteria for myelofibrosis: international Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus … A Tefferi, F Cervantes, R Mesa, F Passamonti, S Verstovsek, ... Blood 122 (8), 1395-1398, 2013 | 260 | 2013 |
| Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report JR Passweg, H Baldomero, P Bader, C Bonini, RF Duarte, C Dufour, ... Bone marrow transplantation 52 (6), 811-817, 2017 | 258 | 2017 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, E Kastritis, E Terpos, P Sonneveld, N Leung, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 253 | 2016 |
| Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet T Barbui, A Tefferi, AM Vannucchi, F Passamonti, RT Silver, R Hoffman, ... Leukemia 32 (5), 1057-1069, 2018 | 238 | 2018 |
| Phase II clinical trial of titanocene dichloride in patients with metastatic breast cancer N Kröger, UR Kleeberg, K Mross, L Edler, DK Hossfeld Oncology Research and Treatment 23 (1), 60-62, 2000 | 235 | 2000 |
| Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant … MG Kiehl, L Kraut, R Schwerdtfeger, B Hertenstein, M Remberger, ... Journal of Clinical Oncology 22 (14), 2816-2825, 2004 | 223 | 2004 |
| Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 50 (4), 476-482, 2015 | 212 | 2015 |
| Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete … M Bornhäuser, J Kienast, R Trenschel, A Burchert, U Hegenbart, ... The lancet oncology 13 (10), 1035-1044, 2012 | 211 | 2012 |
